World's Best Scientists 2026 revealed!
Johan Vansteenkiste

Johan Vansteenkiste

D-Index & Metrics

Medicine

D-Index
107
Citations
85821
World Ranking
6090
National Ranking
66

Overview

Johan Vansteenkiste is affiliated with KU Leuven in Belgium and has a research focus primarily within the field of Medicine, with notable contributions in subfields such as Pulmonary and Respiratory Medicine, Oncology, Hepatology, Immunology, and Surgery.

The scientist's work covers several main topics that emphasize the clinical and molecular aspects of cancer and immunotherapy. These include:

  • Lung Cancer Treatments and Mutations
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Research Studies
  • Colorectal Cancer Treatments and Studies
  • Immunotherapy and Immune Responses
  • Cancer Genomics and Diagnostics

Vansteenkiste's publication record includes contributions to a variety of well-regarded journals with a focus on oncology and thoracic diseases. The frequent publication venues are:

  • Annals of Oncology
  • Journal of Thoracic Oncology
  • Journal of Clinical Oncology
  • Lung Cancer
  • Cancer Research

Some notable papers coauthored in recent years include:

  • Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer, 2020, New England Journal of Medicine
  • Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, 2021, Annals of Oncology
  • Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC-an Update From the PACIFIC Trial, 2021, Journal of Thoracic Oncology
  • Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non-Small-Cell Lung Cancer, 2023, Journal of Clinical Oncology
  • ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer, 2022, Annals of Oncology

The scientist frequently collaborates with the following co-authors:

  • Enriqueta Felip
  • Rebecca S. Heist
  • Corinne Faivre-Finn
  • Harry J.M. Groen
  • Egbert F. Smit

Best Publications

  • International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

    William D Travis;Elisabeth Brambilla;Masayuki Noguchi;Andrew G Nicholson

  • Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

    Jean-Charles Soria;Yuichiro Ohe;Johan Vansteenkiste;Thanyanan Reungwetwattana

  • Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

    Giorgio Vittorio Scagliotti;Purvish Parikh;Joachim von Pawel;Bonne Biesma

  • The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.

    Peter Goldstraw;Kari Chansky;John Crowley;Ramon Rami-Porta

  • Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

    Masahiro Fukuoka;Seiji Yano;Giuseppe Giaccone;Tomohide Tamura

  • Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.

    Arriagada R;Bergman B;Dunant A;Le Chevalier T

  • Atezolizumab Versus Docetaxel for Patients With Previously Treated Non-Small-Cell Lung Cancer (POPLAR): A Multicentre, Open-Label, Phase 2 Randomised Controlled Trial

    Louis Fehrenbacher;Alexander Spira;Marcus Ballinger;Marcin Kowanetz

  • Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

    Scott J. Antonia;Augusto Villegas;Davey Daniel;David Vicente

  • Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up †

    S Novello;F Barlesi;R Califano;R Califano;T Cufer

  • Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC

    Suresh S Ramalingam;Johan Vansteenkiste;David Planchard;Byoung Chul Cho

  • Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer

    Alice T. Shaw;Dong Wan Kim;Ranee Mehra;Daniel S W Tan

  • Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    J. Vansteenkiste;D. De Ruysscher;W.E.E. Eberhardt;E. Lim

  • Phenotype molding of stromal cells in the lung tumor microenvironment.

    Diether Lambrechts;Els Wauters;Bram Boeckx;Sara Aibar

  • Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial

    Ulrich Gatzemeier;Anna Pluzanska;Aleksandra Szczesna;Eckhard Kaukel

  • Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).

    Frank C. Detterbeck;Michael A. Jantz;Michael Wallace;Johan Vansteenkiste

  • Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study

    Pasi A Jänne;Alice T Shaw;José Rodrigues Pereira;Gaëlle Jeannin

  • The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer

    Hisao Asamura;Kari Chansky;John Crowley;Peter Goldstraw

  • The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer

    William D. Travis;Hisao Asamura;Alexander A. Bankier;Mary Beth Beasley

  • Mediastinoscopy vs Endosonography for Mediastinal Nodal Staging of Lung Cancer: A Randomized Trial

    Jouke T. Annema;Jan P. van Meerbeeck;Robert C. Rintoul;Christophe Dooms

  • Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

    S Derijcke;Johan Vansteenkiste

Frequent Co-Authors

Dirk De Ruysscher
Dirk De Ruysscher Maastricht University
Enriqueta Felip
Enriqueta Felip Vall d'Hebron Institut de Recerca
Luis Paz-Ares
Luis Paz-Ares Complutense University of Madrid
Wilfried Eberhardt
Wilfried Eberhardt University of Duisburg-Essen
Suresh Senan
Suresh Senan University of Amsterdam
Solange Peters
Solange Peters University Hospital of Lausanne
Alice T. Shaw
Alice T. Shaw Harvard University
Fabrice Barlesi
Fabrice Barlesi Institut Gustave Roussy

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens many doors, but it’s not the only way to build a rewarding healthcare career. Several healthcare administration degree programs are available online for those interested in leadership, policy, and managing healthcare organizations. This can be a strategic path for those who prefer to work behind the scenes rather than in direct patient care.

Nurses may consider advancing their roles through specialized rn to np bridge programs. These provide a fast-track route from registered nurse to nurse practitioner, opening doors to more autonomous and better-paid positions in the nursing field.

For those drawn to food science and patient wellness, an online bachelor's in nutrition is a flexible way to enter the growing field of dietetics and nutrition counseling.

If you’re aiming even higher in administrative roles, fully online mha programs accredited by CAHME offer advanced courses in healthcare management, policy, and leadership. These online pathways provide flexibility, allowing you to tailor your education to your interests and career aspirations within the healthcare industry.

Best Scientists Citing Johan Vansteenkiste

Trending Scientists

Recently Published Articles